ID
34328
Description
A Study of RO5024048 in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 1 or 4; ODM derived from: https://clinicaltrials.gov/show/NCT01057667
Link
https://clinicaltrials.gov/show/NCT01057667
Keywords
Versions (3)
- 1/16/19 1/16/19 -
- 4/14/19 4/14/19 -
- 4/15/19 4/15/19 -
Copyright Holder
see on clinicaltrials.gov
Uploaded on
January 16, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Hepatitis C, Chronic NCT01057667
Eligibility Hepatitis C, Chronic NCT01057667
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Similar models
Eligibility Hepatitis C, Chronic NCT01057667
- StudyEvent: Eligibility